Cannabis.net

Sep 30, 2024 | cannabis.net | Joseph Billions

In a significant move that could reshape the landscape of cannabis regulation in the United States, a new bill has been introduced in Congress aimed at banning synthetic tetrahydrocannabinol (THC) nationwide. This legislation comes in response to a surge in the availability of unregulated hemp-derived products, particularly those containing synthetic cannabinoids like delta-9 THC.

Sep 27, 2024 | cannabis.net | Joseph Billions

At VIST Labs, innovative cryogenic pasteurization technology addresses one of the industry's most pressing issues: microbial contamination. With more than 100 patents and three decades of experience in food, pharmaceutical, and cannabis packaging, Jim Sanfilippo is revolutionizing cannabis safety. In a market valued at $35 billion, Sanfilippo's breakthroughs are essential for cannabis brands aiming to uphold product quality while managing intricate regulatory hurdles.

Sep 27, 2024 | cannabis.net | Joseph Billions

The Internal Revenue Service (IRS) will persist in pursuing tax payments from marijuana businesses that have taken deductions in anticipation of a potential federal rescheduling, according to a federal agency attorney. If such a reform is implemented, the attorney notes that the IRS could potentially be authorized to seize assets from cannabis companies that fail to meet their tax obligations.

Sep 26, 2024 | cannabis.net | Joseph Billions

Gov. Newsom’s Hemp Ban Goes Into Effect: Consequences for Industry, Investors, and Patients On September 23, 2024, California Governor Gavin Newsom’s emergency ban on hemp-derived THC products officially came into effect, marking a significant shift in the state’s approach to cannabis regulation. This decision has stirred a whirlwind of reactions from various stakeholders, including industry leaders, investors, medical patients, and advocates for cannabis reform.

Sep 24, 2024 | cannabis.net | Joseph Billions

Marijuana rescheduling could permit CBD from hemp in tobacco, but not weed! A recent report from the Congressional Research Service (CRS) has ignited discussions about the potential for incorporating hemp-derived cannabidiol (CBD) into tobacco products, contingent upon the anticipated rescheduling of marijuana.